MARK SCHOENEBAUM is a Senior Managing Director, heads ISI’s Health Care Research Team, and is ISI’s Biotechnology & Pharmaceuticals-Major Analyst. He has been ranked Institutional Investor #1 Biotechnology analyst for the past 9 years. In 2013, his second year competing in the category, Mark was also ranked by Institutional Investor as the #1 Pharmaceuticals/Major analyst. In 2013, Mark was inducted into Institutional Investor’s All-America Research Team Hall of Fame, an award given to analysts who have earned at least ten #1 rankings.
Prior to joining ISI in 2010, Mark spent 2 years at Deutsche Bank as a Managing Director and Senior Biotechnology Analyst. Prior to that, Mark held a similar position at Bear Stearns.
Mark graduated from Indiana University with highest distinction in 1996 with a BA and received an MD from the Johns Hopkins University School of Medicine in 2000.